Elle MD is developing a non-hormonal, easily removable vaginal contraceptive ring intended as a new option for birth control. The company has assembled a team including founder Jennifer Johnston, MD and several named contributors and advisors. It secured C$1.1 million in an oversubscribed pre-seed financing round to advance its program. The immediate plan for the capital is to enable the company's First-in-Human clinical trial at The Ottawa Hospital. The fundraising included multiple institutional and regional investors and local funds. No revenue, user metrics, prior valuations, or earlier funding rounds were disclosed in the announcement.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026